The Effect of Body Weight on Physical Activity Level, Functional Capacity, Balance, and Quality of Life in Individuals With Type 2 Diabetes Mellitus
Bezmialem Vakif University
50 participants
Aug 15, 2025
OBSERVATIONAL
Conditions
Summary
This study aims to investigate the effects of body weight on physical activity level, functional capacity, balance, and quality of life in patients with type 2 diabetes mellitus (T2DM). A total of 50 volunteer patients who meet the inclusion criteria will be recruited from the Internal Medicine and Nutrition outpatient clinics of Bezmialem Vakıf University Hospital. Participants will be prospectively evaluated through face-to-face interviews. Assessments will include body composition analysis (Omron Body Composition Monitor), waist-to-hip ratio, lower extremity muscle strength (Muscle Hand-Held Dynamometer), grip strength (Hand Grip Dynamometer), physical activity level (International Physical Activity Questionnaire-Short Form), functional capacity (6-Minute Walk Test), balance (Biodex Balance System), clinical balance (Berg Balance Scale), and quality of life (Nottingham Health Profile). All statistical analyses will be performed using IBM SPSS Statistics 20. With this study, we aim to comprehensively evaluate multiple parameters in individuals with T2DM and investigate their interrelationships, thereby contributing to the current body of knowledge in the literature.
Eligibility
Inclusion Criteria6
- Having a diagnosis of Type 2 Diabetes Mellitus for at least 1 year
- Being between 18 and 65 years of age
- Having an HbA1c value between 6.5% and 11% at the time of diagnosis
- No cognitive or mental problems
- Ability to walk independently
- Willingness to participate in the study
Exclusion Criteria10
- Presence of uncontrolled cardiovascular and pulmonary disease
- Presence of vertigo or various vestibular system disorders
- Presence of severe neurological or respiratory disease
- History of stroke or myocardial infarction
- Presence of a major musculoskeletal problem
- Presence of chronic renal failure
- Presence of diabetic ulcer or neuropathy
- Pregnancy
- Presence of hemolytic or renal anemia
- Presence of serious visual, hearing, or speech impairments leading to lack of cooperation
Interventions
The demographic, clinical, and personal characteristics of the individuals will be collected and recorded through a questionnaire. For all participants, body fat percentage (%), skeletal muscle mass percentage (%), visceral fat percentage (%), and resting metabolic rate (kcal), measured using the Omron Body Composition Monitor, will be recorded. Waist and hip circumference will be measured with a tape measure; lower extremity muscle strength (M. Quadriceps) will be assessed with a muscle hand-held dynamometer; grip strength will be assessed with a hand grip dynamometer; physical activity level will be evaluated using the International Physical Activity Questionnaire-Short Form (IPAQ-SF); functional capacity will be measured with the 6-Minute Walk Test (6MWT); postural stability and balance will be assessed with the Biodex Balance System; clinical balance will be assessed with the Berg Balance Scale; quality of life will be evaluated using the Nottingham Health Profile (NHP)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07152509